Bocchetta, M., Galluzzi, S., Kehoe, P. G., Aguera, E., Bernabei, R., Bullock, R., Ceccaldi, M., Dartigues, J., de Mendonça, A., Didic, M., Eriksdotter, M., Félician, O., Frölich, L., Gertz, H., Hallikainen, M., Hasselbalch, S. G., Hausner, L., Heuser, I., Jessen, F., Jones, R. W., Kurz, A., Lawlor, B., Lleo, A., Martinez‐Lage, P., Mecocci, P., Mehrabian, S., Monsch, A., Nobili, F., Nordberg, A., Rikkert, M. O., Orgogozo, J., Pasquier, F., Peters, O., Salmon, E., Sánchez‐Castellano, C., Santana, I., Sarazin, M., Traykov, L., Tsolaki, M., Visser, P. J., Wallin, Å. K., Wilcock, G., Wilkinson, D., Wolf, H., Yener, G., Zekry, D., & Frisoni, G. B. (2015). the use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey. Alzheimer's & dementia, 11(2), 195–206.e1. http://access.bl.uk/ark:/81055/vdc_100102758094.0x00001f